相关实验视频
Updated: May 20, 2025
07:07
A Melanoma Patient-Derived Xenograft Model
Published on: May 20, 2019
12.3K
针对晚期牙恶性黑色素瘤的pembrolizumab单一治疗的有效性:一个病例报告
Jie Li1, Chong-Tao Xu2, Wei Wu2
1Department of Stomatology, General Hospital, Tianjin Medical University, No. 154, Anshan Road, Heping District, Tianjin 300052, China; School of Dentistry, Stomatological Hospital, Tianjin Medical University, No. 12, Qixiangtai Road, Heping District, Tianjin 300070, China.
Oral oncology
|March 23, 2025
概括
这项案例研究突出了对先进的口腔恶性黑色素瘤 (一种罕见的癌症) 的 pembrolizumab 单疗法. 治疗显示了治疗潜力,同时也详细说明了与免疫相关的不良事件.
科学领域:
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
背景情况:
- 口腔恶性黑色素瘤是一种罕见的癌症,预后不佳.
- 编程细胞死亡蛋白-1 (PD-1) /PD-L1抑制剂已成为黑色素瘤的治疗方法.
